High-Impact HIV Prevention
I invite you to join a powerful session of CDC’s Public Health Grand Rounds this Tuesday August 21 at 1:00 p.m. (EDT). Grand Rounds at CDC are a forum in which experts present a series of lectures and bring ideas from diverse perspectives on a public health issue.
In this session entitled “High-Impact HIV Prevention,” we will explore the science behind high- impact HIV prevention. HIV surveillance in action and resource allocation modeling of HIV prevention interventions will be presented as well as the White House’s overview of the National HIV/AIDS Strategy implementation.
Because of the good news that HIV incidence is stable and effective treatment exists to prevent illness and death, a growing number of persons—more than 1.1 million—are living with HIV. Approximately one in five of those are not aware that they are infected. Continued growth in the number of people living with HIV—especially those unaware of their infection—ultimately may lead to more infections, if prevention, care and treatment are not targeted to those at greatest risk. At the same time, recent scientific breakthroughs in treatment, prevention, and monitoring disease have equipped us with an unprecedented number of effective tools to prevent infection. To maximize reductions in HIV infections, high-impact prevention seeks to effectively distribute limited resources and combine prevention strategies in the smartest and most effective way possible for the populations and areas most affected by the HIV epidemic.
I am honored to speak in this session on the topic of “Science of Optimizing HIV Prevention.” I am joining the following distinguished colleagues:
Grant Colfax, MD
Director, Office of National AIDS Policy, The White House
Topic: “Overview of the National HIV/AIDS Strategy Implementation”
Irene Hall, PhD, MPH, FACE
Chief, HIV Incidence and Case Surveillance Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Topic: “HIV Surveillance in Action ”
Stephanie Sansom, PhD, MPP, MPH
Commander, U.S. Public Health Service
Lead, Prevention Economics Team
Quantitative Sciences and Data Management Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Topic: “Modeling to Identify Optimal Allocation of HIV Prevention Resources in a City Health Department”
I encourage everyone to watch the live broadcast at either of the following links:
Click here for more information on this event. I hope you will be able to join us for this forum.
In this session entitled “High-Impact HIV Prevention,” we will explore the science behind high- impact HIV prevention. HIV surveillance in action and resource allocation modeling of HIV prevention interventions will be presented as well as the White House’s overview of the National HIV/AIDS Strategy implementation.
Because of the good news that HIV incidence is stable and effective treatment exists to prevent illness and death, a growing number of persons—more than 1.1 million—are living with HIV. Approximately one in five of those are not aware that they are infected. Continued growth in the number of people living with HIV—especially those unaware of their infection—ultimately may lead to more infections, if prevention, care and treatment are not targeted to those at greatest risk. At the same time, recent scientific breakthroughs in treatment, prevention, and monitoring disease have equipped us with an unprecedented number of effective tools to prevent infection. To maximize reductions in HIV infections, high-impact prevention seeks to effectively distribute limited resources and combine prevention strategies in the smartest and most effective way possible for the populations and areas most affected by the HIV epidemic.
I am honored to speak in this session on the topic of “Science of Optimizing HIV Prevention.” I am joining the following distinguished colleagues:
Grant Colfax, MD
Director, Office of National AIDS Policy, The White House
Topic: “Overview of the National HIV/AIDS Strategy Implementation”
Irene Hall, PhD, MPH, FACE
Chief, HIV Incidence and Case Surveillance Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Topic: “HIV Surveillance in Action ”
Stephanie Sansom, PhD, MPP, MPH
Commander, U.S. Public Health Service
Lead, Prevention Economics Team
Quantitative Sciences and Data Management Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Topic: “Modeling to Identify Optimal Allocation of HIV Prevention Resources in a City Health Department”
I encourage everyone to watch the live broadcast at either of the following links:
Click here for more information on this event. I hope you will be able to join us for this forum.
.png)
No hay comentarios:
Publicar un comentario